SWKH
Undervalued by 253.9% based on the discounted cash flow analysis.
Market cap | $175.09 Million |
---|---|
Enterprise Value | $180.19 Million |
Dividend Yield | $4 (28.030833917309%) |
Earnings per Share | $1.09 |
Beta | 0.2 |
Outstanding Shares | 12,229,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 9.55 |
---|---|
PEG | 2.24 |
Price to Sales | 4.76 |
Price to Book Ratio | 0.62 |
Enterprise Value to Revenue | 3.85 |
Enterprise Value to EBIT | 5.66 |
Enterprise Value to Net Income | 9 |
Total Debt to Enterprise | 0.19 |
Debt to Equity | 0.12 |
No data
No data
swk holdings corporation is focused on becoming a market leading innovator in healthcare finance by providing capital to a broad range of life science companies, institutions and inventors. swk’s primary focus is on monetizing cash flow ...